Skip to main content
2025 AANS Annual Scientific Meeting Main banner
Back

    Adam S. Arthur, MD, MPH

    Professor
    UTHSC, Semmes-Murphey Clinic

    Dr Arthur is the James T. Robertson Professor and Chair of the Department of Neurosurgery at the University of Tennessee Health Sciences Center and Semmes-Murphey Clinic, one of the largest and busiest neurosurgical practices in the country. His individual practice is focused on comprehensive treatment for patients with cerebrovascular disease. Dr Arthur has led several large multicenter clinical trials focused on new treatments for hemorrhagic and ischemic stroke patients and is commited to providing exceptional training for residents and fellows.

    Disclosure(s): Arsenal Medical: Consultant (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Balt: Consultant (Ongoing), Grant/Research Support (Ongoing); Bend IT Technologies, Ltd.: Stock Shareholder (excluding mutual funds) (Ongoing); Johnson & Johnson: Consultant (Ongoing), Grant/Research Support (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing); Microvention: Consultant (Ongoing), Grant/Research Support (Ongoing); Neuros Medical: Consultant (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Nuvascular: Consultant (Ongoing); NVMedtech: Consultant (Ongoing); Penumbra: Consultant (Ongoing), Grant/Research Support (Ongoing); Perfuze: Consultant (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); RevBio: Stock Shareholder (excluding mutual funds) (Ongoing); Scientia: Consultant (Ongoing); Serenity Medical, Inc: Stock Shareholder (excluding mutual funds) (Ongoing); Siemens: Consultant (Ongoing), Grant/Research Support (Ongoing); Stryker: Consultant (Ongoing), Grant/Research Support (Ongoing); Synchron Inc: Stock Shareholder (excluding mutual funds) (Ongoing); Tulavi Therapeutics, Inc.: Stock Shareholder (excluding mutual funds) (Ongoing); Vastrax, LLC: Stock Shareholder (excluding mutual funds) (Ongoing)

    Presentation(s):